Marker Therapeutics (MRKR) Earnings Date, Estimates & Call Transcripts

$2.76

0.00 (0.00%)

(As of 12/1/2023 ET)

Compare

Today's Range: $2.69
▼
$2.76
50-Day Range: $2.40
▼
$4.90
52-Week Range: $0.67
▼
$9.68

Volume: 8,756 shs
Average Volume: 19,467 shs
Market Capitalization: $24.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Upcoming Earnings Date: Mar. 27Estimated
Actual EPS (Nov. 9): -$0.34 Missed By -$0.34

Earnings Per Share Revenue

MRKR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRKR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Marker Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	1	($0.12)	($0.12)	($0.12)
Q2 2023	1	($0.13)	($0.13)	($0.13)
Q3 2023	1	($0.14)	($0.14)	($0.14)
Q4 2023	1	($0.14)	($0.14)	($0.14)
FY 2023	4	($0.53)	($0.53)	($0.53)

MRKR Earnings Date and Information

Marker Therapeutics last announced its quarterly earnings data on November 9th, 2023. The reported ($0.34) earnings per share (EPS) for the quarter. The firm earned $0.26 million during the quarter. Marker Therapeutics has generated $0.00 earnings per share over the last year. Marker Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off prior year's report dates.

Marker Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
3/27/2024 Estimated)	-	-	-	-	-	-	-
11/9/2023	Q3 2023	-	($0.34)	($0.34)	($0.34)	-	$0.26 million
8/14/2023	Q2 2023	-	($0.47)	($0.47)	($1.23)	-	$0.76 million
5/16/2023	Q1 2023	-	($0.57)	($0.57)	($0.57)	-	$4.73 million
11/10/2022	Q3 2022	($0.13)	($0.08)	+$0.05	($0.08)	$0.80 million	$3.95 million
8/11/2022	Q2 2022	($0.13)	($0.11)	+$0.02	($0.11)	$2.00 million	$0.79 million
5/13/2022	Q1 2022	($0.13)	($0.12)	+$0.01	($0.12)	-	$0.96 million
Get the Latest News and Ratings for MRKR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
3/17/2022	Q4 2021	($0.12)	($0.12)	-	($0.12)	-	$1.24 million
11/10/2021	Q3 2021	($0.13)	($0.12)	+$0.01	($0.09)	-	-
8/10/2021	Q2 2021	($0.12)	($0.13)	($0.01)	($0.13)	-	-
5/12/2021	Q1 2021	($0.16)	($0.16)	-	($0.16)	-	-
3/8/2021	Q4 2020	($0.16)	($0.18)	($0.02)	($0.18)	-	-

Marker Therapeutics Earnings - Frequently Asked Questions

When is Marker Therapeutics's earnings date?: Marker Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off last year's report dates. Learn more on MRKR's earnings history.
How much revenue does Marker Therapeutics generate each year?: Marker Therapeutics (NASDAQ:MRKR) has a recorded annual revenue of $9.01 million.
How much profit does Marker Therapeutics generate each year?: Marker Therapeutics (NASDAQ:MRKR) has a recorded net income of -$29.93 million. MRKR has generated $0.00 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:MRKR) was last updated on 12/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Marker Therapeutics (MRKR) Earnings Date, Estimates & Call Transcripts

MRKR Earnings Estimates and Actuals by Quarter

MRKR Estimated and Actual Revenue by Quarter

Marker Therapeutics Analyst EPS Estimates

MRKR Earnings Date and Information

Marker Therapeutics Earnings History by Quarter

Marker Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Marker Therapeutics (MRKR) Earnings Date, Estimates & Call Transcripts

Earnings Summary

MRKR Earnings Estimates and Actuals by Quarter

MRKR Estimated and Actual Revenue by Quarter

Marker Therapeutics Analyst EPS Estimates

MRKR Earnings Date and Information

Marker Therapeutics Earnings History by Quarter

Marker Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat